Traumeel S: Bioregulatory Approach to Analgesic Therapy of Spine and Joints Diseases

Bolʹ, Sustavy, Pozvonočnik. 2016;6(3.23):51-56 DOI 10.22141/2224-1507.3.23.2016.85007

 

Journal Homepage

Journal Title: Bolʹ, Sustavy, Pozvonočnik

ISSN: 2224-1507 (Print); 2307-1133 (Online)

Publisher: Zaslavsky O.Yu.

Society/Institution: Ukrainian Association of menopause, andropause and diseases of the musculoskeletal system

LCC Subject Category: Medicine: Medicine (General)

Country of publisher: Ukraine

Language of fulltext: Russian, Ukrainian, English

Full-text formats available: PDF

 

AUTHORS

S.V. Popovych (Ukrainian Academy of Biological Medicine LLC, Kyiv, Ukraine)
O.V. Ivanushko (Ukrainian Academy of Biological Medicine LLC, Kyiv, Ukraine)

EDITORIAL INFORMATION

Double blind peer review

Editorial Board

Instructions for authors

Time From Submission to Publication: 10 weeks

 

Abstract | Full Text

The problem of pain occupies a special place in the theoretical and practical medicine. Pain — the main complaint, forcing seek advice, assistance, one of the most frequent causes of health encounter. Every tenth inhabitant of our planet is experiencing pain associated with dysfunction of the joints and spine, the development of osteoarthritis and degenerative disc disease. The article provides a brief overview of the clinical studies that demonstrate the timeliness of bioregulatory approach use. Traumeel S (manufactured by Biologische Heilmittel Heel GmbH, Germany) is an antiinflammatory drug, which is widely used for the treatment of pain syndrome in inflammatory and degenerative dystrophic diseases, as well as in traumas.